A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

NCT04897022 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Pembrolizumab
RADIATION: IMPRINT

Sponsor

Memorial Sloan Kettering Cancer Center